The use of biomarkers for improved retrospective exposure assessment in epidemiological studies: Summary of an ECETOC workshop

Biomarkers

Volumn 13, Issue 7-8, 2008, Pages 734-748

  Scheepers, Paul T J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gene expression profiling; Histones; Metabonomics; Phosphotriester DNA adducts; Proteomics

Indexed keywords

BIOLOGICAL MARKER; DNA; ENVIRONMENTAL CHEMICAL; HISTONE; INDUSTRIAL CHEMICAL; ORGANIC COMPOUND;

ADIPOSE TISSUE; ARTICLE; BIOLOGICAL MONITORING; CARCINOGENICITY; DNA ADDUCT; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION PROFILING; HAIR; HEALTH HAZARD; HUMAN; KIDNEY; METABOLITE; METABOLOMICS; METHODOLOGY; MOLECULAR EPIDEMIOLOGY; MUTAGENICITY; NAIL; NONHUMAN; OCCUPATIONAL EXPOSURE; PROTEOMICS; RISK ASSESSMENT; SOMATIC MUTATION; TOXICITY TESTING; TOXICOLOGY; WORKSHOP;

BIOLOGICAL MARKERS; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC METHODS; GENE EXPRESSION PROFILING; HUMANS; METABOLOMICS; PROTEOMICS;

EID: 58049191427     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500802528630     Document Type: Article

References (42)

1. Aitio, A., Cabral, JM, Camus, AM, Galendo, D., Bartsch, H. Aitio, ML et al. (1988) Evaluation of sister chromatid exchange as an indicator of sensitivity to N-ethyl-N-nitrosourea-induced carcinogenesis in rats. Teratogenesis, Carcinogenesis, and Mutagenesis, 8, pp. 273-286.
2. Beranek, DT, Weis, CC and Swenson, DH. (1980) A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis, 1, pp. 595-606.
3. Bodell, WJ, Singer, B., Thomas, GH and Cleaver, JE. (1979) Evidence for removal at different rates of O-ethyl pyrimidines and ethylphosphotriesters in two human fibroblast cell lines. Nucleic Acids Research, 6, pp. 2819-2829.
4. Bradford Hill, A. (1965) The environment and disease: Association or causation?. Proceedings of the Royal Society of Medicine, 58, pp. 295-300.
5. Brown, RP, Delp, MD, Lindstedt, SL, Rhomberg, LR and Beliles, RP. (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicology and Industrial Health, 13, pp. 407-484.
6. Clewell, HJ, Gearhart, JM, Gentry, PR, Covington, TR, VanLandingham, CB Crump, KS et al. (1999) Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Analysis, 19, pp. 547-558.
7. Clewell, HJ, Crump, KS, Gentry, PR and Shipp, AM. (2000) Site-specific reference dose for methylmercury for fish-eating populations. Fuel Processing Technology, 65, pp. 43-54.
8. Clewell, HJ, Tan, YM, Campbell, JL and Andersen, ME. (2008) Quantitative interpretation of human biomonitoring data. Toxicology and Applied Pharmacology, 231, pp. 122-133.
9. Deforce, DL, Lemiere, F., Hoes, I., Millecamps, RE, Esmans, EL De Leenheer, A. et al. (1998) Analysis of the DNA adducts of phenyl glycidyl ether in a calf thymus DNA hydrolysate by capillary zone electrophoresis-electrospray mass spectrometry: Evidence for phosphate alkylation. Carcinogenesis, 19, pp. 1077-1086.
10. Doerge, DR, Churchwell, MI, Fang, JL and Beland, FA. (2000) Quantification of etheno-DNA adducts using liquid chromatography, on-line sample processing and electrospray tandem mass spectrometry. Chemical Research in Toxicology, 13, pp. 1259-1264.
11. Ebralidse, KK, Grachev, SA and Mirzabekov, AD. (1988) A highly basic histone H4 domain bound to the sharply bent region of nucleosomal DNA. Nature, 331, pp. 365-367.
12. Eisen, EA, Agaliu, I., Thurston, SW, Coull, BA and Checkoway, H. (2004) Smoothing in occupational cohort studies: An illustration based on penalized spines. Occupational & Environmental Medicine, 61, pp. 854-860.
13. Esteller, M. (2008) Epigenetics in cancer. New England Journal of Medicine, 13, pp. 1148-1159.
14. Fenn, JB, Tanaka, K. and Wutrich, K. (2002) The Nobel Prize in Chemistry, 2002.
15. Hays, SM, Becker, RA, Leung, HW, Aylward, LL and Pyatt, DW. (2007) Biomonitoring equivalents: A screening approach for interpreting biomonitoring results from a public health risk perspective. Regulatory Toxicology and Pharmacology, 47, pp. 96-109.
16. Heederik, H. and Attfield, M. (2000) Characterization of dust exposure for the study of chronic occupational lung disease: A comparison of different exposure assessment strategies. American Journal of Epidemiology, 15, pp. 982-990.
17. Jenuwein, T. and Allis, CD. (2001) Translating the histone code. Science, 293, pp. 1074-1080.
18. Jones, PA and Baylin, SB. (2002) The fundamental role of epigenetic events in cancer. Nature Review Genetics, 3, pp. 415-428.
19. Jonsson, F., Bois, F. and Johanson, G. (2001) Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise. Toxicological Sciences, 59, pp. 209-218.
20. Jonsson, F. and Johanson, G. (2002) Physiologically based modeling of the inhalation kinetics of styrene in humans using a Bayesian population approach. Toxicology and Applied Pharmacology, 179, pp. 35-49.
21. Kanaly, RA, Hanaoka, T., Sugimura, H., Toa, H., Matsui, S. and Matsuda, T. (2006) Development of the adductome approach to detect DNA damage in humans. Antioxidants & Redox Signaling, 8, pp. 993-1001.
22. Kensler, TW, Gange, SJ, Egner, PA, Dolan, PM, Munoz, A. Groopman, JD et al. (1997) Predictive value of molecular dosimetry: Individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiology. Biomarkers & Prevention, 6, pp. 603-610.
23. Kirk, GD, Lesi, OA, Mendy, M., Szymanska, K., Whittle, H. Goedert, JJ et al. (2005) 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene, 24, pp. 5858-5867.
24. Lan, Q., Zhang, L., Li, G., Vermeulen, R., Weinberg, RS Dosemeci, M. et al. (2004) Hematotoxicity in workers exposed to low levels of benzene. Science, 306, pp. 1774-1776.
25. Lin, YS, Kupper, LL and Rappaport, SM. (2005) Air sampling versus biomarkers for epidemiology. Occupational & Environmental Medicine, 62, pp. 750-760.
26. Maccubbin, AE, Caballes, L., Riordan, JM, Huang, DH and Gurtoo, HL. (1991) A cyclophosphamide-DNA phosphoester adduct formed in vitro and in vivo. Cancer Research, 51, pp. 886-892.
27. Marsden, DA, Jones, DJL, Lamb, JH, Tomins, EM, Farmer, PD and Brown, K. (2007) Determination of endogenous and exogenously derived N7-(2-hydroxyethyl)guanine adducts in ethylene oxide-treated rats. Chemical Research in Toxicology, 20, pp. 290-299.
28. Noort, D., Benschop, HP and Black, RM. (2002) Biomonitoring of exposure to chemical warfare agents: A review. Toxicology and Applied Pharmacology, 184, pp. 116-126.
29. Ozbal, CC, Velic, I., SooHOo, CK, Skipper, PL and Tannenbaum, SR. (1994) Conservation of histone carcinogen adducts during replication: implications for long-term molecular dosimetry. Cancer Research, 54, pp. 5599-5601.
30. Pearce, N. (1994) Occupational exposures to carcinogens in developing countries. Annals of the Academy of Medicine. Singapore, 23, pp. 684-689.
31. Ross, RK, Yuan, J-M, Yu, MC, Wogan, GN, Qian, G-S, Tu, J-T, Groopman, JD, Gao, Y-T and Henderson, BE. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, pp. 943-946.
32. Shipp, AM, Gentry, PR, Lawrence, G., Van Landingham, C., Covington, T. Clewell, H. J. et al. (2000) Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicology and Industrial Health, 16, pp. 335-438.
33. Singer, B. (1985) In vivo formation and persistence of modified nucleosides resulting from alkylating agents. Environmental Health Perspectives, 62, pp. 41-48.
34. Singh, R. and Famer, PB. (2006) Liquid chromatograph-electrospray ionization-mass spectrometry: The future of DNA-adduct detection. Carcinogenesis, 27, pp. 178-196.
35. Singh, R., Gaskell, M., Le Pla, RC, Kaur, B., Azim-Araghi, A. Roach, J. et al. (2006) Detection and quantitation of benzo[a]pyrene-derived DNA adducts in mouse liver by liquid chromatography-tandem mass spectrometry: Comparison with 32P-postlabeling. Carcinogenesis, 19, pp. 868-878.
36. Tornqvist, M., Fred, C., Haglund, J., Helleberg, H., Paulsson, B. and Rydberg, P. (2002) Protein adducts: Quantitative and qualitative aspects of their formation, analysis and applications. Journal of Chromatography B, 778, pp. 279-308.
37. Turner, BM. (2002) Cellular memory and the histone code. Cell, 111, pp. 285-291.
38. Turner, TC, Sylla, A., Gong, YY, Diallo, MS, Sutcliff, AE and Hall, AJ. (2005) Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in West Africa: A community-based intervention study. Lancet, 365, pp. 1950-1956.
39. Wild, C. (2005) Complementing the genome with an 'exposome': The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology, Biomarkers & Prevention, 14, pp. 1847-1850.
40. (2008) John Wiley and Sons, Chichester, UK
41. Yates, JM, Fennell, TR, Turner, MJ, Recio, L. and Sumner, SC. (1994) Characterization of phosphodiester adducts produced by the reaction of cyanoethylene oxide with nucleotides. Carcinogenesis, 15, pp. 277-283.
42. Yong, AJ and Hay, JB. (2005) Rapid turnover of the recirculating lymphocyte pool in vivo. International Immunology, 7, pp. 1607-1615.